644.2000 3.85 (0.60%)
NSE Jul 04, 2025 15:31 PM
Volume: 165.7K
 

644.20
0.60%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd. is trading below its 30 day SMA of 646.6
More from Syngene International Ltd.
Recommended